HRP20010956B1 - Makrolidi - Google Patents
MakrolidiInfo
- Publication number
- HRP20010956B1 HRP20010956B1 HR20010956A HRP20010956A HRP20010956B1 HR P20010956 B1 HRP20010956 B1 HR P20010956B1 HR 20010956 A HR20010956 A HR 20010956A HR P20010956 A HRP20010956 A HR P20010956A HR P20010956 B1 HRP20010956 B1 HR P20010956B1
- Authority
- HR
- Croatia
- Prior art keywords
- macrolides
- azithromycin
- monohydrate
- stable
- processes
- Prior art date
Links
- 239000003120 macrolide antibiotic agent Substances 0.000 title 1
- 229940041033 macrolides Drugs 0.000 title 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 abstract 2
- 229960004099 azithromycin Drugs 0.000 abstract 2
- 150000004682 monohydrates Chemical class 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
Abstract
Postupak za proizvodnju spoja formulenaznačen time, da sadrži korake: i) obrada spoja formules boriranim hidridom, ii) hidroliziranje boratnog međuspoja nastalog u prisutnosti polihidroksiliranog spoja; te prema želji, iii) izoliranje spoja formule III iz reakcijske smjese. Patent sadrži još 4 patentna zahtjeva.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9915216.7A GB9915216D0 (en) | 1999-06-29 | 1999-06-29 | Organic compounds |
GBGB9915218.3A GB9915218D0 (en) | 1999-06-29 | 1999-06-29 | Organic compounds |
GBGB9930059.2A GB9930059D0 (en) | 1999-12-20 | 1999-12-20 | Organic compounds |
PCT/EP2000/005948 WO2001000640A1 (en) | 1999-06-29 | 2000-06-27 | Macrolides |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP20010956A2 HRP20010956A2 (en) | 2003-08-31 |
HRP20010956B1 true HRP20010956B1 (hr) | 2010-09-30 |
Family
ID=27269768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20010956A HRP20010956B1 (hr) | 1999-06-29 | 2001-12-24 | Makrolidi |
Country Status (10)
Country | Link |
---|---|
US (1) | US6703372B1 (hr) |
EP (2) | EP1189915B1 (hr) |
JP (2) | JP4703924B2 (hr) |
KR (1) | KR100700475B1 (hr) |
AT (2) | ATE469910T1 (hr) |
AU (1) | AU5820400A (hr) |
DE (3) | DE20023815U1 (hr) |
ES (2) | ES2346782T3 (hr) |
HR (1) | HRP20010956B1 (hr) |
WO (1) | WO2001000640A1 (hr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HRP20020231A2 (en) * | 2002-03-18 | 2003-12-31 | Pliva D D | ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A |
CA2245398C (en) | 1998-08-21 | 2002-01-29 | Apotex Inc. | Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof |
WO2002010144A1 (es) | 2000-07-25 | 2002-02-07 | Laboratorio Silanes, S.A. De C.V. | PROCESO PARA LA PREPARACION EN UN SOLO PASO DE 7,16-DIOXA-2-AZA-10-O-CLADINOSIL-12-O-DESOSAMINIL-4,5-DIHIDROXI-6-ETIL-3,5,9,11,13,15-HEXAMETILBICICLO[11.2.1]HEXADECA-1(2)-EN-8-ONA Y OBTENCION DE UNA FORMA NUEVA DE 9-DESOXO-9a-AZA-9a-METIL-9a-HOMOERITROMICINA A |
ES2172417B1 (es) * | 2000-07-31 | 2003-09-16 | Sint Quimica Sa | Nueva forma mejorada de azitromicina monohidrato de menor higroscopicidad, procedimiento de preparacion y composiciones farmaceuticas que la comprenden. |
HU229488B1 (hu) | 2000-11-27 | 2014-01-28 | Sandoz Ag | Eljárás makrolid hidrátok elõállítására |
HRP20010301A2 (en) * | 2001-04-27 | 2001-12-31 | Pliva D D | New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases |
SI1390377T1 (sl) * | 2001-05-22 | 2006-06-30 | Pfizer Prod Inc | Nova kristalna oblika azitromicina |
US6861413B2 (en) | 2001-05-22 | 2005-03-01 | Pfizer Inc. | Stable non-dihydrate azithromycin oral suspensions |
ATE404575T1 (de) * | 2001-05-22 | 2008-08-15 | Pfizer Prod Inc | Neue kristallforme von azithromycin |
PL371125A1 (en) * | 2001-12-21 | 2005-06-13 | Pfizer Products Inc. | Methods for wet granulating azithromycin |
US20050209446A1 (en) * | 2002-02-26 | 2005-09-22 | Meiji Seika Kaisha Ltd. | Novel 15-membered cyclic azalide, novel 16-membered cyclic diazalide derivative, and process for producing these |
JP2005522470A (ja) * | 2002-04-03 | 2005-07-28 | ハンミ ファーム. シーオー., エルティーディー. | アジスロマイシンの製造方法及びそれに用いられる9−デオキソ−9a−アザ−9a−ホモエリスロマイシンAの結晶性水和物 |
ITMI20021209A1 (it) * | 2002-06-04 | 2003-12-04 | Chemi Spa | Processo di preparazione di azitromicina ad elevata purezza |
GB0214277D0 (en) * | 2002-06-20 | 2002-07-31 | Biochemie Gmbh | Organic compounds |
US6855813B2 (en) | 2002-07-19 | 2005-02-15 | Alembic Limited | Process for the preparation of azithromycin monohydrate |
HRP20020614A2 (en) | 2002-07-22 | 2004-06-30 | PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. | Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a |
GB0224197D0 (en) * | 2002-10-17 | 2002-11-27 | Biochemie Gmbh | Organic compounds |
US20050013835A1 (en) * | 2003-07-15 | 2005-01-20 | Pfizer Inc. | Stable non-dihydrate azithromycin oral suspensions |
US20060189800A1 (en) * | 2003-07-24 | 2006-08-24 | Mitsuru Ohkubo | Indolopyrrolocabazole derivative and antitumor agent |
PL1648473T3 (pl) * | 2003-07-24 | 2009-07-31 | Pliva Hrvatska D O O | Pojedyncza dawka szybko rozpuszczającej się azytromycyny |
US7384921B2 (en) * | 2004-02-20 | 2008-06-10 | Enanta Pharmaceuticals, Inc. | Polymorphic forms of 6-11 bicyclic ketolide derivatives |
US7468428B2 (en) * | 2004-03-17 | 2008-12-23 | App Pharmaceuticals, Llc | Lyophilized azithromycin formulation |
US20060116336A1 (en) * | 2004-03-17 | 2006-06-01 | American Pharmaceutical Partners, Inc. | Lyophilized azithromycin formulation |
US7683162B2 (en) | 2004-08-30 | 2010-03-23 | Taro Pharmaceutical Industries Limited | Process of preparing a crystalline azithromycin monohydrate |
EP1827449A4 (en) * | 2004-11-17 | 2008-01-23 | Smithkline Beecham Corp | USE OF NOVEL ANTIBACTERIAL COMPOUNDS |
CN101177441B (zh) * | 2007-12-05 | 2012-05-23 | 浙江耐司康药业有限公司 | 一种稳定的阿奇霉素一水合物结晶的制备方法 |
CN101445532B (zh) * | 2008-12-30 | 2011-09-21 | 广东东阳光药业有限公司 | 阿奇霉素一水合物结晶的制备方法 |
KR20120004448A (ko) | 2009-03-13 | 2012-01-12 | 다 볼떼라 | 그람음성 박테리아 제거용 조성물 및 방법 |
CN102417531B (zh) * | 2011-12-20 | 2014-06-11 | 浙江国邦药业有限公司 | 一种阿奇霉素一水合物的制备方法 |
CN105030704B (zh) * | 2015-06-29 | 2018-09-07 | 石药集团欧意药业有限公司 | 阿奇霉素片剂及其制备方法 |
CN110684056B (zh) * | 2018-07-05 | 2021-07-13 | 青岛农业大学 | 一种阿奇霉素中间体的化学合成方法 |
CN114516895A (zh) * | 2020-11-19 | 2022-05-20 | 江苏威奇达药业有限公司 | 一种阿奇霉素胺结晶方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0298650A2 (en) * | 1987-07-09 | 1989-01-11 | Pfizer Inc. | Azithromycin dihydrate |
WO1998041532A1 (en) * | 1997-03-14 | 1998-09-24 | Biochemie S.A. | Erythromycin a oxime dihydrate |
EP0941999A2 (en) * | 1998-03-13 | 1999-09-15 | Hovione Inter Ltd. | Preparation of azithromycin dihydrate |
EP0984020A2 (en) * | 1998-08-21 | 2000-03-08 | Apotex Inc. | Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof. |
WO2000027856A1 (en) * | 1998-11-10 | 2000-05-18 | Biochemie S.A. | Macrolide intermediates |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA835204B (en) * | 1982-07-19 | 1985-02-27 | Pfizer | N-methyl 11-aza-10-deoxo-10-dihydroerythromycin a,intermediates therefor and processes for their preparation |
ES2122905B1 (es) * | 1996-07-11 | 1999-11-16 | Astur Pharma Sa | Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato). |
ES2224425T3 (es) * | 1997-07-08 | 2005-03-01 | Sandoz Ag | Compuestos organicos. |
-
2000
- 2000-06-27 WO PCT/EP2000/005948 patent/WO2001000640A1/en active IP Right Grant
- 2000-06-27 ES ES06117687T patent/ES2346782T3/es not_active Expired - Lifetime
- 2000-06-27 DE DE20023815U patent/DE20023815U1/de not_active Expired - Lifetime
- 2000-06-27 JP JP2001507048A patent/JP4703924B2/ja not_active Expired - Fee Related
- 2000-06-27 DE DE60044515T patent/DE60044515D1/de not_active Expired - Fee Related
- 2000-06-27 AT AT06117687T patent/ATE469910T1/de not_active IP Right Cessation
- 2000-06-27 KR KR1020017016822A patent/KR100700475B1/ko not_active IP Right Cessation
- 2000-06-27 EP EP00943902A patent/EP1189915B1/en not_active Expired - Lifetime
- 2000-06-27 US US10/019,500 patent/US6703372B1/en not_active Expired - Lifetime
- 2000-06-27 EP EP06117687A patent/EP1712556B1/en not_active Expired - Lifetime
- 2000-06-27 AU AU58204/00A patent/AU5820400A/en not_active Abandoned
- 2000-06-27 ES ES00943902T patent/ES2267549T3/es not_active Expired - Lifetime
- 2000-06-27 DE DE60029589T patent/DE60029589T2/de not_active Expired - Lifetime
- 2000-06-27 AT AT00943902T patent/ATE334136T1/de not_active IP Right Cessation
-
2001
- 2001-12-24 HR HR20010956A patent/HRP20010956B1/hr not_active IP Right Cessation
-
2011
- 2011-01-31 JP JP2011017553A patent/JP2011126894A/ja active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0298650A2 (en) * | 1987-07-09 | 1989-01-11 | Pfizer Inc. | Azithromycin dihydrate |
WO1998041532A1 (en) * | 1997-03-14 | 1998-09-24 | Biochemie S.A. | Erythromycin a oxime dihydrate |
EP0941999A2 (en) * | 1998-03-13 | 1999-09-15 | Hovione Inter Ltd. | Preparation of azithromycin dihydrate |
EP0984020A2 (en) * | 1998-08-21 | 2000-03-08 | Apotex Inc. | Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof. |
WO2000027856A1 (en) * | 1998-11-10 | 2000-05-18 | Biochemie S.A. | Macrolide intermediates |
Also Published As
Publication number | Publication date |
---|---|
WO2001000640A1 (en) | 2001-01-04 |
ATE334136T1 (de) | 2006-08-15 |
JP2011126894A (ja) | 2011-06-30 |
DE60044515D1 (de) | 2010-07-15 |
EP1189915B1 (en) | 2006-07-26 |
AU5820400A (en) | 2001-01-31 |
US6703372B1 (en) | 2004-03-09 |
DE20023815U1 (de) | 2006-06-08 |
JP4703924B2 (ja) | 2011-06-15 |
ES2346782T3 (es) | 2010-10-20 |
EP1712556A1 (en) | 2006-10-18 |
KR20020016862A (ko) | 2002-03-06 |
EP1189915A1 (en) | 2002-03-27 |
ATE469910T1 (de) | 2010-06-15 |
KR100700475B1 (ko) | 2007-03-28 |
DE60029589D1 (de) | 2006-09-07 |
JP2003503417A (ja) | 2003-01-28 |
EP1712556B1 (en) | 2010-06-02 |
DE60029589T2 (de) | 2007-07-19 |
HRP20010956A2 (en) | 2003-08-31 |
ES2267549T3 (es) | 2007-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20010956B1 (hr) | Makrolidi | |
ZA9811939B (en) | Novel macrolides. | |
ZA9811940B (en) | Novel erythromycin derivatives. | |
HK1047942A1 (en) | Purine derivatives. | |
HK1047110A1 (en) | Purine derivatives. | |
HK1047111A1 (en) | Purine derivatives. | |
ZA99254B (en) | Benzosulfone derivatives. | |
HK1034978A1 (en) | Adenosine derivatives. | |
ZA985018B (en) | 9-oxime erythromycin derivatives. | |
ZA200103289B (en) | Novel macrolide antibiotics. | |
ZA200107346B (en) | Erythromycin derivatives. | |
HK1034969A1 (en) | Dihydroxyhexanoic acid derivatives. | |
ZA991550B (en) | Cyclohexanediole derivatives. | |
AU2579299A (en) | Supplied air snorkeling device | |
SG83135A1 (en) | Di-or triaza-spiro(4,5)decane derivatives | |
GB2371457B (en) | An arrangement for H.323 proxies | |
ZA983902B (en) | Erythromycin derivatives. | |
PL353770A1 (en) | Streptomyces avermitilis | |
ZA200004983B (en) | Lightweight draft arm. | |
HK1057047A1 (en) | Processes for preparing erythromycin derivatives and intermediates thereof. | |
HK1054024A1 (en) | Processes for producing tetrahydropyranyl-4-sulfonate and 4-aminotetrahydropyran compound. | |
MXPA03000920A (es) | Derivado de eritromicina y medicamento que comprende lo mismo. | |
HUP0102518A3 (en) | 5-imino-13-deoxy anthracycline derivatives, their uses, and processes for preparing them | |
PL353874A1 (en) | Streptomyces avermitilis | |
PL352760A1 (en) | Oxathiepino[6,5-b |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
B1PR | Patent granted | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20150506 Year of fee payment: 16 |
|
PBON | Lapse due to non-payment of renewal fee |
Effective date: 20160627 |